• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot Setting.新型普立思 Max 连续性肾脏替代治疗系统在多国多中心的初步设置中。
Blood Purif. 2018;46(3):220-227. doi: 10.1159/000489213. Epub 2018 Jun 19.
2
Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System.新型 PrisMax 持续肾脏替代治疗系统与经典 Prismaflex 系统准确性的比较。
Blood Purif. 2019;47(1-3):166-170. doi: 10.1159/000494764. Epub 2018 Nov 14.
3
A First Evaluation of OMNI®, A New Device for Continuous Renal Replacement Therapy.新型持续肾脏替代治疗设备OMNI®的首次评估
Blood Purif. 2017;43(1-3):11-17. doi: 10.1159/000451053. Epub 2016 Nov 16.
4
ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study).ACUsmart 持续肾脏替代治疗平台：技术和临床评估的多中心试点研究（A.M.P. 研究）。
Blood Purif. 2019;48(1):60-66. doi: 10.1159/000496090. Epub 2019 Feb 1.
5
Comparison of circuit patency and exchange rates between 2 different continuous renal replacement therapy machines.比较两种不同连续性肾脏替代治疗机的回路通畅率和汇率。
J Crit Care. 2014 Apr;29(2):272-7. doi: 10.1016/j.jcrc.2013.11.012. Epub 2013 Nov 25.
6
Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal.急性肾损伤中肾脏替代治疗的量化和剂量：再评价。
Blood Purif. 2017;44(2):140-155. doi: 10.1159/000475457. Epub 2017 Jun 7.
7
Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey.澳大利亚和新西兰重症监护病房急性肾损伤的肾脏替代治疗：一项实践调查。
Crit Care Resusc. 2008 Sep;10(3):225-30.
8
Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.股动脉通路与持续性肾脏替代治疗剂量的给予
Blood Purif. 2016;41(1-3):11-7. doi: 10.1159/000439581. Epub 2015 Oct 20.
9
Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy.在重症监护病房中进行肾脏替代治疗的二甲双胍相关性乳酸酸中毒：意大利西北部五百万人口的基于人群研究。
Blood Purif. 2017;44(3):198-205. doi: 10.1159/000471917. Epub 2017 Jul 1.
10
Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.用于PrismaFlex持续肾脏替代治疗的局部枸橼酸盐抗凝法。
Ann Pharmacother. 2009 Sep;43(9):1419-25. doi: 10.1345/aph.1M182. Epub 2009 Aug 18.

引用本文的文献

1
Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients.Tablo 治疗时间延长（XTEND）研究的扩展：Tablo 在危重症患者中成功进行 24 小时延长治疗。
BMC Nephrol. 2022 Oct 21;23(1):338. doi: 10.1186/s12882-022-02968-4.
2
Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View.从技术角度看联合体外肺和肾支持的趋势、优势与劣势
Front Med Technol. 2022 Jun 21;4:909990. doi: 10.3389/fmedt.2022.909990. eCollection 2022.
3
Hemofiltration in Patients with Severe Acute Pancreatitis (Review).重症急性胰腺炎患者的血液滤过（综述）
Sovrem Tekhnologii Med. 2020;12(1):105-121. doi: 10.17691/stm2020.12.1.14.
4
ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study).ACUsmart 持续肾脏替代治疗平台：技术和临床评估的多中心试点研究（A.M.P. 研究）。
Blood Purif. 2019;48(1):60-66. doi: 10.1159/000496090. Epub 2019 Feb 1.

本文引用的文献

1
Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.早期与延迟启动肾脏替代治疗对急性肾损伤危重症患者死亡率的影响：ELAIN 随机临床试验。
JAMA. 2016;315(20):2190-9. doi: 10.1001/jama.2016.5828.
2
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.重症监护病房肾脏替代治疗的启动策略。
N Engl J Med. 2016 Jul 14;375(2):122-33. doi: 10.1056/NEJMoa1603017. Epub 2016 May 15.
3
Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?临床综述：连续肾脏替代治疗的抗凝——肝素还是柠檬酸盐？
Crit Care. 2011 Jan 24;15(1):202. doi: 10.1186/cc9358.
4
Intensity of continuous renal-replacement therapy in critically ill patients.危重症患者持续肾脏替代治疗的强度
N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413.
5
Intensity of renal support in critically ill patients with acute kidney injury.急性肾损伤危重症患者的肾脏支持强度
N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20.
6
A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.一种用于代谢控制和高溶质清除的实用枸橼酸盐抗凝连续性静脉-静脉血液透析滤过方案。
Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. doi: 10.2215/CJN.00040505. Epub 2005 Nov 23.
7
[Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics].[动静脉血液滤过：治疗对利尿剂抵抗的水过多患者的一种新的简单方法]
Klin Wochenschr. 1977 Nov 15;55(22):1121-2. doi: 10.1007/BF01477940.

新型普立思 Max 连续性肾脏替代治疗系统在多国多中心的初步设置中。

The Novel PrisMax Continuous Renal Replacement Therapy System in a Multinational, Multicentre Pilot Setting.

机构信息

Department of Perioperative and Intensive Care, Skåne University Hospital, Lund, Sweden.

Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Blood Purif. 2018;46(3):220-227. doi: 10.1159/000489213. Epub 2018 Jun 19.

DOI:10.1159/000489213
PMID:29920488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6106140/
Abstract

BACKGROUND/AIMS: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in a prospective international multicentre setting. We compared this device to its predecessor, the Prismaflex, with regards to multiple treatment parameters. Additionally, we performed a survey, aiming to measure user satisfaction.

METHODS

Data was prospectively collected from 7 intensive care units (ICU) in 6 countries. The PrisMax device data logs constituted the raw material. Clinical parameters like treatment time, filter life span, downtime, delivered dose and number and type of alarms were recorded. A user questionnaire was sent out to 3 of the participating ICUs.

RESULTS

Filter life, downtime, blood pump stops, bag changing time and number of malfunction alarms showed significantly improved values compared to the historic Prismaflex data. The survey showed high scores with regards to user friendliness.

CONCLUSION

The PrisMax CRRT device is safe and outperformed its' previous generation counterpart in virtually all aspects. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=489213.

摘要

背景/目的：我们评估了新型 PrisMax 连续肾脏替代治疗（CRRT）系统在前瞻性国际多中心环境中的表现。我们将该设备与其前代产品 Prismaflex 进行了比较，比较了多个治疗参数。此外，我们还进行了一项旨在衡量用户满意度的调查。

方法

数据是从 6 个国家的 7 个重症监护病房（ICU）前瞻性收集的。PrisMax 设备的数据日志构成了原始材料。记录了治疗时间、过滤器寿命、停机时间、输送剂量以及报警的数量和类型等临床参数。向参与的 3 个 ICU 发送了用户调查问卷。

结果

与历史 Prismaflex 数据相比，过滤器寿命、停机时间、血液泵停止、更换袋子时间和故障报警数量显著改善。调查显示，用户友好度评分很高。

结论

PrisMax CRRT 设备安全且在几乎所有方面都优于其前代产品。视频期刊俱乐部“克劳迪奥·罗恩科的卡布奇诺”，网址为：http://www.karger.com/?doi=489213。